Free Trial

Vivos Therapeutics (VVOS) Institutional Ownership

Vivos Therapeutics logo
$3.47 -0.17 (-4.67%)
Closing price 04:00 PM Eastern
Extended Trading
$3.52 +0.05 (+1.41%)
As of 08:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Institutional Ownership Changes (13F Filings) for Vivos Therapeutics (NASDAQ:VVOS)

Current
Institutional Ownership
Percentage
26.35%
Number of
Institutional Buyers
(last 12 months)
7
Total
Institutional Inflows
(last 12 months)
$1.64M
Number of
Institutional Sellers
(last 12 months)
1
Total
Institutional Outflows
(last 12 months)
$75.14K
Get VVOS Insider Trade Alerts

Want to know when executives and insiders are buying or selling Vivos Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

VVOS Institutional Buying and Selling by Quarter

Vivos Therapeutics Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
8/19/2025 B. Riley Wealth Advisors Inc.69,531$220K0.0%N/A1.180%
8/12/2025 XTX Topco Ltd20,528$65K0.0%N/A0.349%
5/1/2025Cutter & CO Brokerage Inc.49,100$140K0.0%+28.9%0.834%
4/22/2025EWA LLC10,464$30K0.0%N/A0.178%
2/17/2025Anson Funds Management LP242,583$1.04M0.1%N/A4.119%
2/12/2025Geode Capital Management LLC44,827$192K0.0%+55.6%0.761%
2/10/2025Commonwealth Equity Services LLC26,000$112K0.0%+23.8%0.441%
2/4/2025Cutter & CO Brokerage Inc.38,100$163K0.0%N/A0.647%
10/24/2024Strategic Wealth Investment Group LLC100,000$252K0.0%-22.4%2.096%
2/13/2024Armistice Capital LLC57,000$709K0.0%N/A4.286%
1/16/2024Strategic Wealth Investment Group LLC128,789$1.60M0.2%-96.0%9.683%
4/24/2023Strategic Wealth Investment Group LLC3,219,705$1.10M0.2%N/A12.874%
4/20/2023Strategic Wealth Investment Group LLC232,737$1.10M0.2%N/A0.931%
4/18/2023Godsey & Gibb Inc.92,999$32K0.0%N/A0.372%
2/10/2023Bard Associates Inc.201,704$81K0.0%-6.9%0.806%
11/16/2022SeaCrest Wealth Management LLC40,000$26K0.0%N/A0.174%
11/9/2022Boston Partners78,454$51K0.0%-36.8%0.341%
11/4/2022Russell Investments Group Ltd.365,901$236K0.0%-11.1%1.590%
10/24/2022Perkins Capital Management Inc.56,500$37K0.0%-65.5%0.246%
7/29/2022Perkins Capital Management Inc.163,800$211K0.2%+9.2%0.712%
7/29/2022Russell Investments Group Ltd.411,589$530K0.0%-3.1%1.789%
5/10/2022Boston Partners137,354$368K0.0%+27.2%0.597%
5/5/2022Russell Investments Group Ltd.424,801$1.14M0.0%+39.2%1.846%
5/2/2022National Asset Management Inc.98,574$265K0.0%+24.4%0.428%
4/20/2022Perkins Capital Management Inc.150,050$402K0.3%+10.3%0.652%
4/12/2022Griffin Asset Management Inc.70,200$188K0.0%+63.3%0.305%
2/10/2022Perkins Capital Management Inc.136,050$306K0.2%-7.1%0.591%
2/4/2022Boston Partners108,015$243K0.0%+131.5%0.469%
2/3/2022Cambridge Investment Research Advisors Inc.19,200$43K0.0%+60.0%0.083%
1/28/2022Griffin Asset Management Inc.43,000$97K0.0%-13.1%0.187%
1/28/2022National Asset Management Inc.79,270$179K0.0%+55.5%0.344%
1/21/2022Russell Investments Group Ltd.305,096$684K0.0%+554.0%1.326%
11/16/2021Schonfeld Strategic Advisors LLC34,443$139K0.0%N/A0.151%
11/16/2021National Asset Management Inc.50,987$206K0.0%+46.9%0.224%
11/16/2021Two Sigma Investments LP157,324$636K0.0%N/A0.690%
11/12/2021WMS Partners LLC12,167$49K0.0%-27.0%0.053%
11/12/2021Blueshift Asset Management LLC18,826$76K0.0%N/A0.083%
11/9/2021BlackRock Inc.48,905$198K0.0%+255.8%0.214%
11/8/2021Avalon Investment & Advisory329,322$1.33M0.0%+73.6%1.444%
11/8/2021Russell Investments Group Ltd.46,651$188K0.0%N/A0.205%
11/5/2021Boston Partners46,651$188K0.0%N/A0.205%
11/2/2021Cambridge Investment Research Advisors Inc.12,000$48K0.0%-68.0%0.053%
10/25/2021Perkins Capital Management Inc.146,500$592K0.4%-9.8%0.642%
8/17/2021Walleye Capital LLC150,000$743K0.0%N/A0.658%
8/16/2021WMS Partners LLC16,667$153K0.0%N/A0.073%
8/16/2021Archon Capital Management LLC215,000$1.06M0.1%N/A0.942%
8/13/2021Renaissance Technologies LLC19,200$95K0.0%N/A0.084%
8/13/2021Northern Trust Corp11,483$57K0.0%N/A0.050%
8/13/2021Geode Capital Management LLC47,661$235K0.0%+285.0%0.209%
8/13/2021Vanguard Group Inc.383,891$1.90M0.0%N/A1.683%
8/12/2021Bard Associates Inc.215,500$1.07M0.3%N/A0.945%
8/11/2021Millrace Asset Group Inc.93,993$465K0.2%N/A0.412%
8/10/2021National Asset Management Inc.34,718$172K0.0%+21.9%0.152%
8/10/2021Cambridge Investment Research Advisors Inc.37,551$186K0.0%N/A0.165%
(Data available from 1/1/2016 forward)

VVOS Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of VVOS shares?

During the previous two years, 9 institutional investors and hedge funds held shares of Vivos Therapeutics. The most heavily invested institutionals were Anson Funds Management LP ($1.04M), Armistice Capital LLC ($709K), Strategic Wealth Investment Group LLC ($252K), B. Riley Wealth Advisors Inc. ($220K), Geode Capital Management LLC ($192K), Cutter & CO Brokerage Inc. ($140K), and Commonwealth Equity Services LLC ($112K).Learn more on Vivos Therapeutics' institutional investors.

What percentage of Vivos Therapeutics' stock is owned by institutional investors?

26.35% of Vivos Therapeutics' stock is owned by institutional investors. Learn more on VVOS's institutional investor holdings.

Which institutional investors have been buying Vivos Therapeutics' stock?

The following institutional investors have purchased Vivos Therapeutics' stock in the last 24 months: Anson Funds Management LP ($242.58K), B. Riley Wealth Advisors Inc. ($69.53K), Armistice Capital LLC ($57K), Cutter & CO Brokerage Inc. ($49.10K), XTX Topco Ltd ($20.53K), Geode Capital Management LLC ($16.03K), and EWA LLC ($10.46K).

How much institutional buying is happening at Vivos Therapeutics?

Institutional investors have bought a total of 413,231 shares in the last 24 months. This purchase volume represents approximately $1.64M in transactions.

Which of Vivos Therapeutics' major shareholders have been selling company stock?

The following institutional investors have sold Vivos Therapeutics stock in the last 24 months: Strategic Wealth Investment Group LLC ($28.79K).

How much institutional selling is happening at Vivos Therapeutics?

Institutional investors have sold a total of 28,789 shares in the last 24 months. This volume of shares sold represents approximately $75.14K in transactions.



This page (NASDAQ:VVOS) was last updated on 9/12/2025 by MarketBeat.com Staff
From Our Partners